Delivery Order SPE2DR25D2100-SPE2DR26FA0BC
Award Date 11/12/25
Potential Completion Date 11/13/25
Potential Value $99K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,249.50 delivery order to AmerisourceBergen Drug Corp for Lantus 100 Unit/ML vials (10 mL) on September 17, 2025, with an ultimate completion date of September 18, 2025. The contract utilizes firm fixed pricing and represents a non-set-aside award issued competitively. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters and a major pharmaceutical distribution hub supporting federal medical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, for Lantus SoloStar 100 Unit/mL 3mL insulin products. This firm fixed-price contract, valued at $1,218.64, represents a competitive award with no set-aside designation and is scheduled for completion by September 26, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lantus 100 Unit/mL vials (10mL) with a ceiling value of $1,626.00. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and has an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp has been awarded a firm fixed-price delivery order valued at $1,278.50 by the Defense Logistics Agency (DLA) for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The award, issued on August 8, 2025, represents a competitive procurement with no set-aside designation and is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for Lantus SoloStar 100 Unit/mL insulin pens with a ceiling value of $1,022.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,187.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- AmerisourceBergen Drug Corp has been awarded a competitively competed delivery order by the Defense Logistics Agency (DLA) for Lantus SoloStar 100 Unit/ML insulin pens, valued at $1,294.28. The order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery requirement from its corporate office location....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $4,398.30. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical to provide $1,248.33 worth of Lantus 100 unit/ml vials. The delivery order requires 10 ml vials of the insulin medication to be delivered to a DLA Troop Support Medical facility in Conshohocken, Pennsylvania by December 12, 2023. No set-aside designation was applied to this...